Showing results (81-90 of 177) with videos related to

Sort By:
Pageof 18
Tissue Antigens|March 1, 1980
Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell linesM S Pollack, P O Livingston, J Fogh, et al.
International Journal of Cancer|December 15, 1989
Expression of TAG-72 in normal colon, transitional mucosa, and colon cancerM Xu, F X Real, S Welt, et al.
Immunobiology|December 1, 1990
Antibody response to immunization with purified GD3 ganglioside and GD3 derivatives (lactones, amide and gangliosidol) in the mouseG Ritter, E Boosfeld, M J Calves, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Serological survey of normal humans for natural antibody to cell surface antigens of melanomaA N Houghton, M C Taormina, H Ikeda, et al.
International Journal of Cancer|May 30, 1991
Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanomaG Ritter, E Boosfeld, R Adluri, et al.
The Journal of Experimental Medicine|May 1, 1988
A transformation-associated 130-kD cell surface glycoprotein is growth controlled in normal human cellsC E Klein, H L Ozer, F Traganos, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1978
Serological analysis of cell surface antigens of malignant human brain tumorsM Pfreundschuh, H Shiku, T Takahashi, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Tumor-specific antigensM Pfreundschuh, H Shiku, T Takahashi, et al.
Cancer Treatment Reports|May 1, 1984
Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trialS E Krown, M W Burk, J M Kirkwood, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1980
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodiesW G Dippold, K O Lloyd, L T Li, et al.
Pageof 18